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ABSTRACT
Background: The long-term longitudinal evidence for a relation
between coffee intake and hypertension is relatively scarce.
Objective: The objective was to assess whether coffee intake is
associated with the incidence of hypertension.
Design: This study was conducted on a cohort of 2985 men and 3383
women who had a baseline visit and follow-up visits after 6 and 11 y.
Baseline coffee intake was ascertained with questionnaires and cat-
egorized into 0, 0–3, 3–6, and 6 cups/d. Hypertension was
defined as a mean systolic blood pressure (SBP)140 mm Hg over
both follow-up measurements, a mean diastolic blood pressure
(DBP)90 mm Hg over both follow-up measurements, or the use of
antihypertensive medication at any follow-up measurement.
Results: Coffee abstainers at baseline had a lower risk of hyperten-
sion than did those with a coffee intake of0–3 cups/d [odds ratio
(OR): 0.54; 95% CI: 0.31, 0.92]. Women who drank6 cups/d had
a lower risk than did women who drank 0–3 cups/d (OR: 0.67;
95% CI: 0.46, 0.98). Subjects aged39 y at baseline had 0.35 mm
Hg (95% CI:0.59,0.11 mm Hg) lower SBP per cup intake/d and
0.11 mm Hg lower DBP (95% CI: 0.26, 0.03 mm Hg) than did
those aged39 y at baseline, although the difference in DBP was not
statistically significant.
Conclusions: Coffee abstinence is associated with a lower hyper-
tension risk than is low coffee consumption. An inverse U-shaped
relation between coffee intake and risk of hypertension was observed
in the women. Am J Clin Nutr 2007;85:718–23.
KEY WORDS Coffee, hypertension, cohort study
INTRODUCTION
Coffee consumption has long been a suspected cause of hy-
pertension, but the available evidence from various study designs
is inconsistent. Many randomized experiments have been per-
formed but with different coffee or caffeine intakes. In a recent
meta-analysis of 16 trials with both coffee and caffeine interven-
tions, we showed that for coffee trials with a median intake of 725
mL coffee/d there was a rise of 1.2 mm Hg in systolic blood
pressure and of 0.5 mm Hg in diastolic blood pressure (1). These
trials were designed for a short follow-up duration.
Most evidence on the relation between coffee and blood pres-
sure stems from cross-sectional studies. This evidence, however,
is inconsistent. Some of these studies showed a positive relation
(2), no relation (3), or even an inverse relation (4). Such cross-
sectional studies have important limitations with respect to
causal inference.
Conclusive information about coffee as a cause for hyperten-
sion cannot be expected to come from randomized trials, because
those would require unrealistically long-term interventions.
Rather, long-term observational cohort studies will have to pro-
vide such information. There have been few follow-up studies on
the relation between coffee intake and blood pressure or risk of
hypertension (5, 6, 7). In 1017 young men, a small positive
association between coffee intake and blood pressure rise over
many years of follow-up was indicated to play a small role in the
development of hypertension (6). In women participating in the
Nurse’s Health Studies, an inverse U-shaped relation was re-
cently found between hypertension and caffeine consumption,
but no association was found with caffeinated coffee consump-
tion (7).
Because the long-term longitudinal evidence for a relation
between coffee intake and hypertension is relatively scarce, we
used a Dutch cohort study to address that issue. This cohort
allowed for studying the relation of baseline coffee intake to the
incidence of persistent hypertension on the basis of repeatedly
measured blood pressure levels in subjects at 5 y intervals during
a follow-up of 11 y. Our specific research question was whether
coffee intake in subjects who are not hypertensive is associated
with the incidence of hypertension.
SUBJECTS AND METHODS
The design of the Doetinchem Cohort Study is described in
detail elsewhere (8). Briefly, the subjects were inhabitants of the
Dutch city of Doetinchem who had participated in 2 subsequent
general population screening projects for chronic disease risk
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factors: the Monitoring Project on Cardiovascular Disease Risk
Factors [Peilstationsproject Hart- en Vaatziekten (PPHV)] (9)
conducted between 1987 and1991, and the Monitoring Project
on Risk Factors for Chronic Diseases–European Prospective In-
vestigation into Cancer and Nutrition (MORGEN-EPIC) (10)
conducted between 1993 and 1997. The subjects were invited for
a third separate visit between 1998 and 2002. The response rate
was 62% at baseline, 78% at the first follow-up, and again 78%
at the third follow-up. Respondents who attended the baseline
and at least one of the follow-up examinations were included in
the present analysis (n 6368). The median follow-up time was
11 y. The study was approved by the Medical Ethics Committee
of the Organization for Applied Scientific Research-Zeist, Neth-
erlands. All subjects signed an informed consent form.
Dietary variables and exposure categories
Coffee intake at baseline of PPHV was estimated by the ques-
tion “How many cups of coffee do you drink per day?,” a question
on the type of coffee used (regular, decaffeinated, or other), and
a question about the use of additives (none, milk, sugar, etc). In
MORGEN-EPIC, the subjects were asked to indicate how fre-
quently they usually drank coffee, the type of coffee [regular
(instant), decaffeinated, or other], use of additives (sugar, milk,
and type of milk) with color photographs to indicate the strength
of coffee and the standard size of a cup equaling 125 g. In a
food-frequency questionnaire, the respondents were instructed
to record what, on average, they had eaten and drunk in the past
year. The MORGEN-EPIC food-frequency questionnaire was
also used in the third follow-up (11). Similar questions were
asked about tea intake. Coffee intake at baseline was divided into
4 categories: 0 cups/d, 0–3 cups/d, 3–6 cups/d, and 6
cups/d. The category of0–3 cups/d was chosen as the reference
category rather than the non-coffee drinking category because it
contained larger numbers of subjects and yielded more stable
estimates.
At baseline of PPHV, the subjects filled out a mailed ques-
tionnaire about demography, family history of cardiovascular
disease, other chronic disease (eg, diabetes mellitus), current
medication use, prescribed diets, selected dietary habits, and
reproductive history for women. Pregnant women were excluded
from the study. Questionnaires were used to assess alcohol intake
(glasses/d), smoking status (none, ever, or current smoking of
cigarettes), educational level (low, medium, or high) based on
highest educational level achieved, and occupational status (paid
work, housekeeping, unemployed, or retired or other).
Anthropometric and biological variables
Body height was measured to the nearest 0.5 cm without shoes.
Body weight was measured without shoes and heavy clothing to
the nearest 0.1 kg.
At all visits, nonfasting blood samples were obtained by using
a standardized protocol. Plasma total and HDL cholesterol were
measured at the Clinical Chemistry Laboratory of the University
Hospital “Dijkzigt” in Rotterdam, which is the Lipid Reference
Laboratory for standardized cholesterol determinations in the
Netherlands. Total cholesterol was measured enzymatically by
using a Boehringer test kit (12). HDL-cholesterol concentrations
were measured after precipitation of apolipoprotein B–contain-
ing lipoproteins with magnesium phosphotungstate (13).
Outcome measurements and definitions
In PPHV, blood pressure was measured by trained technicians
using a random zero sphygmomanometer while the subject was
in a sitting position. The cuff size (12 23 cm) was applied to the
left upper arm. A larger cuff (15 33 cm) was used in 1.1% and
a smaller cuff (9  18 cm) in 0.4% of all examined subjects.
Systolic blood pressure was recorded at the appearance of sounds
(first-phase Korotkoff) and diastolic blood pressure at the disap-
pearance of sounds (fifth-phase Korotkoff). After the first mea-
surement, the heart rate was measured for 30 s followed by a
second blood pressure measurement. In MORGEN-EPIC and at
the third visit, the blood pressure measurement procedure was
identical to that performed in PPHV. No restrictions were made
with regard to coffee drinking before the measurements were
taken.
Hypertension was defined by using cutoffs according to the
recommendations in the 7th report of the Joint National Com-
mittee (JNC) of the National Heart, Lung, and Blood Institute
(14), which classifies stage 1 hypertension as a systolic blood
pressure of 140–159 mm Hg or a diastolic blood pressure of
90–99 mm Hg and stage 2 hypertension as having systolic blood
pressure of160 mm Hg or diastolic blood pressure100 mm
Hg, use of antihypertensive medication, or both. To have suffi-
cient numbers of hypertensives in each category of coffee intake,
these categories of hypertension were pooled to at least JNC
stage 1 hypertension. Persistent hypertension was defined as
having a mean systolic blood pressure140 mm Hg or a mean
diastolic blood pressure 90 mm Hg calculated over both
follow-up measurements at a 5-y interval, the use of antihyper-
tensive medication at any of the follow-up measurements, or
both. The association between baseline coffee intake and inci-
dent hypertension as defined above was assessed among those
who did not have hypertension at baseline. No hypertension at
baseline was defined as having a systolic blood pressure 140
mm Hg and a diastolic blood pressure 90 mm Hg and no use
antihypertensive medication.
Statistical analysis
The association between baseline coffee intake and incident
hypertension as defined above was assessed among those who
did not have hypertension at baseline as defined above. Logistic
regression was used with presence of persistent hypertension
(yes or no) as the dependent variable and baseline coffee intake
and confounders as independent variables. Furthermore, effects
of changes in coffee intake as a predictor of change of blood
pressure were examined. A repeated-measures analysis with
time-varying covariates was used with changes between re-
peated blood pressure measurements as dependent variables and
time-varying changes in coffee intake and confounders as inde-
pendent variables. In all analyses, we adjusted for the following
possible confounders: age, sex, body height and weight, smok-
ing, alcohol intake, tea intake, educational level, occupational
status, and total energy intake.
All analyses were expressed as measures of association with
corresponding 95% CIs, regarding intervals not including the
respective null values as statistically significant. Analyses were
performed by using SPSS version 11.0 or SAS Proc Mixed for
repeated-measures analysis (SPSS Inc, Chicago, IL).
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RESULTS
The baseline characteristics at the first round (1987 to 1991) of
the Doetinchem cohort are shown in Table 1. The prevalence of
hypertension, as defined in Methods, at baseline was 23% in the
men and 14.5% in the women.
The associations between baseline coffee intake and the sub-
sequent development of persistent hypertension among normo-
tensives at baseline are shown in Table 2. The interaction be-
tween sex and coffee intake in relation to hypertension was
borderline statistically significant (P  0.08), and therefore we
decided to do both sex-specific analyses and analysis of the total
group. The unadjusted odds ratios indicated a lower risk among
noncoffee drinkers than in those who drank0–3 cups/d. After
adjustment, this association was slightly attenuated but was still
detectable in the total group. Furthermore, women who drank6
cups/d had a lower risk of hypertension than did women who
drank0–3 cups/d. Among coffee drinking women, there was a
statistically significant trend over coffee intake categories (P
0.023). Because age played a central role in confounding adjust-
ments, we further explored to what extent the association be-
tween baseline coffee intake and later blood pressure differed
with age. In linear regression models with the mean systolic or
diastolic blood pressure from the last 2 visits as the dependent
variable and coffee intake (cups), age, and a coffee intake age
interaction term as independent variables, there was a statisti-
cally signficant interaction for systolic blood pressure (P 
0.0001) as well as for diastolic blood pressure (P 0.0001). The
association between baseline coffee intake and systolic and di-
astolic blood pressure by median age at baseline and after full
adjustment in the subjects who were not treated for hypertension
at baseline is shown in Figure 1. Below the median age, there
was no significant relation between coffee and blood pressure.
In the group above the median, there was an inverse relation
for systolic blood pressure (linear regression coefficient:
0.35 mm Hg  cup1  d1; 95% CI: 0.59, 0.11 mm
Hg  cup1  d1) and diastolic blood pressure (0.11 mm
TABLE 1
Baseline characteristics of the study cohort (n 6368)
Men
(n 2985)
Women
(n 3383) P1
Age (y) 40.7 10.02 40.1 10.3 0.0009
Body height (cm) 178.9 6.8 165.9 6.3 0.0001
Body weight (kg) 81.1 10.6 67.8 10.8 0.0001
Systolic blood pressure (mm Hg) 125.6 13.6 117.5 14.8 0.0001
Diastolic blood pressure (mm Hg) 79.4 10.3 75.5 10.3 0.0001
Total cholesterol (mmol/L) 5.6 1.1 5.4 1.0 0.0001
HDL cholesterol (mmol/L) 1.1 0.3 1.4 0.3 0.0001
Normotensive (%)3 77.0 85.5 0.0001
Previous myocardial infarction (%) 0.9 0.1 0.0001
Diabetes mellitus (%) 0.7 0.7 0.96
Current cigarette smoker (%) 34.9 33.8 0.35
Education level (%) 0.0001
Low 55.3 68.7
Middle 24.5 18.7
High 20.2 12.6
Occupational status (%) 0.0001
Paid work 86 43.1
Housekeeping 0.7 48.8
Unemployed or retired 8.6 5.3
Other 4.7 2.7
Coffee intake 0.0001
0 cups/d4 2.9 5.2
3 cups/d 15.7 27.0
3–6 cups/d 53.1 53.9
6 cups/d 28.3 13.5
Coffee intake (g/d) 625 (125–3000)5 500 (62.5–2500) 0.0001
Decaffeinated coffee user (no.) 327 509 0.0001
Decaffeinated coffee intake (g/d) 375 (125–3125) 375 (62.5–1875) 0.03
Tea intake (g/d) 300 (150–3000) 300 (150–2250) 0.0001
Alcohol intake (glasses/d) 1.1 (0–14) 0 (0–7) 0.0001
Total energy intake (kJ) 8119.9 (1984.6) 6331.4 (1941.1) 0.0001
Follow-up (y) 11.0 0.18 11.0 0.17
1 Differences in continuous data were tested by using Student’s t test; difference in median no. of glasses alcohol/d was tested by using Mann-Whitney
U test; and differences in proportional data were tested by using chi-square tests.
2 x  SD (all such values).
3 Systolic blood pressure140 mm Hg and diastolic blood pressure90 mm Hg and no antihypertensive treatment (14).
4 1 cup 125g.
5 Median; min-max in parentheses (all such values).
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Hg  cup1d1; 95% CI: 0.26, 0.03 mm Hg  cup1  d1),
although the latter was not statistically significant.
No statistically significant associations between change of
coffee intake and blood pressure change were observed among
the cohort members not receiving antihypertensive drug treat-
ment at any visit. No clear association was evident between
intake of every extra cup of coffee and either systolic blood
pressure (0.08 mm Hg/cup change in coffee intake; 95% CI:
0.23, 0.07 mm Hg/cup change in coffee intake; P  0.31) or
diastolic blood pressure (0.05 mm Hg/cup change in coffee
intake; 95% CI:0.16, 0.06 mm Hg/cup change in coffee intake;
P  0.37) over the total follow-up time. Adjustment for the
change in confounders, such as age, body height and weight, total
cholesterol, energy intake, tea intake, alcohol intake, smoking,
education level, and sex, did not significantly change these find-
ings (systolic blood pressure: 0.06 mm Hg/cup change in coffee
intake; 95% CI:0.11, 0.22 mm Hg/cup change in coffee intake;
P 0.48; diastolic blood pressure:0.06 mm Hg/cup change in
coffee intake; 95% CI:0.18, 0.06 mm Hg/cup change in coffee
intake; P  0.34). Exclusion of non-coffee drinkers from the
analysis did not significantly influence these findings.
Finally, we found in our cohort a lower risk of persistent
hypertension in the 231 total abstainers from coffee than in the
411 users of strictly decaffeinated coffee. Using stage 1 or stage
2 hypertension as outcome, the unadjusted odds ratio was 0.35
(95% CI: 0.20, 0.60). Adjustment for confounding attenuated
this odds ratio to a nonsignificant 0.72 (95% CI: 0.34, 1.49).
DISCUSSION
Our study indicates that both abstainers from coffee and, in
women only, heavy consumers (6 cups/d) have lower risks of
hypertension than do low coffee consumers (0–3 cups/d). An
association between higher coffee consumption and lower blood
pressure seems to be present only after middle age.
Nonresponses may have been related to coffee intake or blood
pressure, but not likely to specific associations between coffee
and blood pressure. We cannot rule out that professional advice
to lower coffee consumption to persons with higher baseline
intakes has led to a spurious association between higher intake
and lower blood pressure. However, we analyzed persons who
were normotensive at baseline to whom such advice was unlikely
given. Although there may be residual or unmeasured confound-
ing, we accounted for most confounders that are known to be risk
factors for high blood pressure. We had no baseline information
about intake of caffeine-containing sodas, which was recently
shown to be associated with incidence of hypertension (7). We
can only speculate about the effects of adjustment for that intake,
but consumption of such sodas in the Netherlands in middle-aged
persons in that period was probably low. A strong feature of our
study is that it pertains to a large sample from the general pop-
ulation with 10 y of follow-up. Moreover, our outcome clas-
sification—the incidence of hypertension persisting over a 5-y
period—better reflects true hypertension incidence than does
measurement at a single occasion. This outcome was based on
actual blood pressure measurements or hypertension treatment,
TABLE 2
Relative risk for persistent hypertension occurrence in 11 y follow-up by baseline categories of coffee intake in 5189 normotensive subjects in the study
cohort1
Coffee intake Total cohort No hypertension Hypertension OR (95% CI) OR adjusted (95% CI)2
n n n
Men
0 cups/d 65 59 6 0.40 (0.17, 0.96)3 0.60 (0.24, 1.49)
0–3 cups/d 379 302 77 1.00 1.00
3–6 cups/d 1195 928 267 1.13 (0.85, 1.50) 1.08 (0.79, 1.47)
6 cups/d 658 515 143 1.09 (0.80, 1.49) 1.03 (0.72, 1.46)
Women
0 cups/d 166 155 11 0.38 (0.20, 0.71)3 0.51 (0.26, 1.01)
0–3 cups/d 794 668 126 1.00 1.00
3–6 cups/d 1542 1275 267 1.11 (0.88, 1.40) 0.83 (0.64, 1.07)
6 cups/d 390 331 59 0.95 (0.68, 1.32) 0.67 (0.46, 0.98)3
Total
0 cups/d 231 214 17 0.38 (0.23, 0.64)3 0.54 (0.31, 0.92)3
0–3 cups/d 1173 970 203 1.00 1.00
3–6 cups/d 2737 2203 534 1.16 (0.97, 1.38) 0.93 (0.76, 1.12)
6 cups/d 1048 846 202 1.14 (0.92, 1.42) 0.83 (0.65, 1.07)
1 Hypertension was defined as having at least stage 1 hypertension (mean systolic blood pressure over both follow-up measurements140 mm Hg, mean
diastolic blood pressure over both follow-up measurements90 mm Hg, or the use of antihypertensive medication at any of both follow-up measurements)
(14). Normotensive subjects at baseline were defined as having a systolic blood pressure140 mm Hg and a diastolic blood pressure90 mmHg and use of
no antihypertensive medication. Odds ratios (ORs) were obtained from logistic regression with persistent hypertension (yes or no) as the dependent variable
and dummy categories of coffee intake and adjustment factors as independent variables. The category of 0–3 cups coffee/d was the reference group. The
interaction between sex and coffee intake in relation to hypertension was borderline statistically significant (P 0.08). Among coffee drinking women, there
was a statistically significant trend over coffee intake categories (P 0.023).
2 Adjusted for baseline age, height and weight, smoking, alcohol intake, tea intake, education level, occupational status, and total energy intake. For the
analysis of the total cohort, sex was added to the adjustment model.
3 The OR was statistically significant.
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rather than on self-reporting of a physician diagnosis, such as in
the Nurse’s Health Study (7). Finally, although we have ad-
dressed a limited number of hypotheses concerning the associ-
ation between coffee intake and hypertension, we cannot rule out
chance as an explanation, neither for the main effects nor for the
interactions with age.
Our findings in men agree with those of a previous report on a
long-term follow-up conducted in 1017 males showing a non-
significant relation between coffee intake and hypertension in-
cidence, despite a small positive effect on blood pressure levels
(6). Our findings in women may be compatible with recent find-
ings in the women participating in the Nurse’s Health Studies I
and II, where an inverse U-shaped association was found be-
tween caffeinated coffee intake and hypertension risk (7).
Among normotensives at baseline, we showed a lower hyperten-
sion risk for coffee abstainers than for users of0–3 cups/d.
From short-term randomized trials, it is known that coffee and
caffeine have a blood pressure–raising effect (1). The prevailing
explanation for such effect is that caffeine antagonizes endoge-
nous adenosine, resulting in vasoconstriction and elevated total
peripheral vascular resistance (15). The question is how low
coffee intake is associated with a higher risk of hypertension,
whereas high coffee intake is not. One explanation could be that
effects of coffee on blood pressure do depend on consumption
habits, with higher blood pressure levels observed in nonhabitual
than in habitual coffee consumers (16, 17). Thus, a higher hy-
pertension risk in consumers of0–3 cups/d than in nondrinkers
and consumers of6 cups/d may be based on a lower adaptation
to the effects of coffee when used in moderate to low amounts.
Alternatively, coffee may have more general protective effects,
because our finding of heavier coffee intake leading to lower
blood pressure does not seem to be specific. A lower risk for type
2 diabetes mellitus in heavy coffee users compared with non- or
moderate users was first shown by one of us (18) and recently
confirmed by others (19-23) and is somewhat stronger in women
than in men (21). In agreement with our findings for hyperten-
sion, it was shown that women with low coffee use (1 cup/d)
had a higher risk of type 2 diabetes mellitus than did non-coffee
users (20). However, it remains unclear whether and to what
extent an association between coffee intake and blood pressure
can explain the association with diabetes mellitus. Some studies
could only adjust for known hypertension (18, 23), which may be
misclassified and leave residual confounding by blood pressure
as an explanation. One study adjusted for systolic blood pressure
levels, whereas diastolic blood pressure levels were most
strongly associated with diabetes mellitus risk (21). In other
studies, there was no explicit adjustment for blood pressure or
hypertension (19, 20, 22). Finally, there may be a blood pressure–
lowering compound in coffee that explains lower hypertension
risk with higher intake. It was recently shown in a cross-sectional
study that higher habitual tea intake was associated with lower
risk of hypertension (24). This effect of tea combined with our
observations on coffee may indicate a central role of serum po-
tassium concentrations. A higher intake of potassium is clearly
associated with lower blood pressure (25), and tea and particu-
larly coffee are rich sources of potassium in Western diets (26).
This, however, would not explain the observed lower hyperten-
sion risk in coffee abstainers.
Overall, higher baseline coffee intake in our study was asso-
ciated with lower later blood pressure only from middle age
onwards, wheras there was no such relation in younger persons.
We can only speculate about the mechanisms for such age-
dependent effects. It may agree with the results from short-term
randomized trials, in which blood pressure–raising effects of
coffee were reported to be stronger in younger than in older
subjects (1) and which may point at more habituation to coffee in
older persons (15, 16). Alternatively, if there is a protective salt
constituent in coffee, such as potassium, it may be through in-
creasing salt-sensitivity and higher blood pressure levels ob-
served with increasing age (27, 28) that the protective effects of
higher coffee intake become apparent. Finally, there is recent
evidence to suggest that genetically determined slow caffeine
metabolism in relation to cardiovascular disease risk is present
only in relatively younger persons (29).
From a public health point of view, a direct implication of our
study may be to reduce the incidence of hypertension by mea-
sures aimed at refraining from moderate coffee intake, but that
would be unpractical if at all effective. The most important merit
of our study is the elucidation of the role of coffee intake through
its relation with hypertension in increasing the risk of cardiovas-
cular disease. Although there are reports claiming coffee to be
hazardous (30, 31), the larger cohorts show no association be-
tween coffee intake and cardiovascular morbidity or mortality
(32) or with the prognosis of myocardial infarction (33). We
consider it likely that the extent to which coffee intake explains
FIGURE 1. Linear regression coefficients (95% CIs) representing the
difference in mean systolic (■) and diastolic (F) blood pressures over the 2
follow-up visits per each extra daily cup of coffee at baseline, separated by
those aged below and above the median age (39 y) at baseline in the study
cohort. Data pertain to 5694 subjects without antihypertensive treatment at
any visit. All estimates are adjusted for sex, height and weight, smoking,
alcohol intake, tea intake, total cholesterol, HDL cholesterol, education level,
occupational status, and total energy intake. In linear regression models with
the mean systolic or diastolic blood pressure from the 2 follow-up visits as the
dependent variable and coffee intake (in cups), age, and an coffee intake 
age interaction term as independent variables, there was a statistically sig-
nificant interaction for systolic blood pressure and for diastolic blood pres-
sure (P 0.0001 for both). 95% CIs not crossing the null line are considered
statistically significant.
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hypertension risk is too small to be detected in relation to car-
diovascular disease. A practical implication from our findings
would therefore be to abstain from professional advice concern-
ing coffee intake in normotensive individuals, which indeed
agrees with the latest clinical guidelines on hypertension (14).
We cannot preclude that associations between coffee intake and
cardiovascular outcomes are different among hypertensive indi-
viduals (34). In conclusion, coffee abstinence was associated
with a lower hypertension risk than was low coffee consumption,
and an inverse U-shaped relation between coffee intake and risk
of hypertension was observed in women.
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